Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In Africa, at least 240,000 children are born each year with sickle cell disease. Historically, in the absence of newborn screening and appropriate treatment, most such children died undiagnosed in early childhood. However, with increasing awareness of the condition and economic and epidemiologic transition, increasing numbers are surviving. Greater investments in basic and applied research in the African context, and increased sensitization or African ministries of health regarding the importance of this condition, could make a substantial difference to the lives and livelihoods of millions of people living with sickle cell disease on the continent and their families.

Original publication

DOI

10.1016/j.hoc.2015.11.005

Type

Journal

Hematology/oncology clinics of North America

Publication Date

04/2016

Volume

30

Pages

343 - 358

Addresses

Department of Medicine, Imperial College of Science, Technology and Medicine, St Mary's Hospital, Praed Street, London W21N, UK; Department of Epidemiology and Demography, KEMRI/Wellcome Trust Research Programme, PO Box 230, Kilifi, Kenya. Electronic address: tom.williams@imperial.ac.uk.

Keywords

Humans, Anemia, Sickle Cell, Cause of Death, Age Factors, Comorbidity, Mutation, Cost of Illness, Delivery of Health Care, Africa South of the Sahara, beta-Globins, Global Health